WallStreetZenWallStreetZen

NASDAQ: ALVO
Alvotech Stock Forecast, Predictions & Price Target

Analyst price target for ALVO

Based on 2 analysts offering 12 month price targets for Alvotech.
Min Forecast
$10.00-18.17%
Avg Forecast
$15.00+22.75%
Max Forecast
$20.00+63.67%

Should I buy or sell ALVO stock?

Based on 2 analysts offering ratings for Alvotech.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALVO stock forecasts and price targets.

ALVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2023-10-20

1 of 1

Forecast return on equity

Is ALVO forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is ALVO forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ALVO revenue forecast

What is ALVO's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$319.2M+241.78%
Avg 2 year Forecast
$598.5M+540.93%
Avg 3 year Forecast
$909.0M+873.38%
ALVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALVO revenue growth forecast

How is ALVO forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
112.82%
Industry
8.5%
Market
10.52%
ALVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALVO vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ALVO$12.22$15.00+22.75%Buy
HCM$16.80$19.55+16.37%Buy
INDV$21.42N/AN/A
PBH$72.56N/AN/A
EVO$7.83N/AN/A

Alvotech Stock Forecast FAQ

Is Alvotech Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ALVO) stock is to Buy ALVO stock.

Out of 2 analysts, 1 (50%) are recommending ALVO as a Strong Buy, 0 (0%) are recommending ALVO as a Buy, 1 (50%) are recommending ALVO as a Hold, 0 (0%) are recommending ALVO as a Sell, and 0 (0%) are recommending ALVO as a Strong Sell.

If you're new to stock investing, here's how to buy Alvotech stock.

What is ALVO's revenue growth forecast for 2024-2026?

(NASDAQ: ALVO) Alvotech's forecast annual revenue growth rate of 112.82% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Alvotech's revenue in 2024 is $93,382,000.On average, 2 Wall Street analysts forecast ALVO's revenue for 2024 to be $85,159,393,375, with the lowest ALVO revenue forecast at $80,046,553,200, and the highest ALVO revenue forecast at $90,272,500,371. On average, 2 Wall Street analysts forecast ALVO's revenue for 2025 to be $159,697,409,605, with the lowest ALVO revenue forecast at $146,752,014,200, and the highest ALVO revenue forecast at $172,643,071,833.

In 2026, ALVO is forecast to generate $242,530,916,966 in revenue, with the lowest revenue forecast at $242,530,916,966 and the highest revenue forecast at $242,530,916,966.

What is ALVO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALVO) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is ALVO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ALVO price target, the average ALVO price target is $15.00, with the highest ALVO stock price forecast at $20.00 and the lowest ALVO stock price forecast at $10.00.

On average, Wall Street analysts predict that Alvotech's share price could reach $15.00 by Mar 22, 2025. The average Alvotech stock price prediction forecasts a potential upside of 22.75% from the current ALVO share price of $12.22.

What is ALVO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALVO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.